APA (7th ed.) Citation

TK, L., KM, W., & MJ, F. (2018). Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 24(8), 599. https://doi.org/10.1177/1078155217722405

Chicago Style (17th ed.) Citation

TK, Liebenstein, Widmer KM, and Fallon MJ. "Retrospective Analysis of Goal Drug Level Attainment of Posaconazole for Invasive Fungal Infection Prophylaxis in Patients with Acute Myeloid Leukemia Pre- and Post-switch to Tablet Formulation." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 24, no. 8 (2018): 599. https://doi.org/10.1177/1078155217722405.

MLA (9th ed.) Citation

TK, Liebenstein, et al. "Retrospective Analysis of Goal Drug Level Attainment of Posaconazole for Invasive Fungal Infection Prophylaxis in Patients with Acute Myeloid Leukemia Pre- and Post-switch to Tablet Formulation." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 24, no. 8, 2018, p. 599, https://doi.org/10.1177/1078155217722405.